Skip to content
Independent analysis of NHS open data
PharmaInsight

Dolutegravir/Abacavir/Lamivudine vs Oseltamivir phosphate

National NHS prescribing compared (Prescription Cost Analysis)
Data updated April 2026

Oseltamivir phosphate was dispensed 336.0× as often as Dolutegravir/Abacavir/Lamivudine in April 2026 — 336 items versus 1 in England.

1items

Dolutegravir/Abacavir/Lamivudine · April 2026

NHSBSA Prescription Cost Analysis

336items

Oseltamivir phosphate · April 2026

NHSBSA Prescription Cost Analysis

Figure 1. Dolutegravir/Abacavir/Lamivudine versus Oseltamivir phosphate: national items dispensed by month

▬ Dolutegravir/Abacavir/Lamivudine   ·   ╌ Oseltamivir phosphate

0 8k 15k Mar 2026 Apr 2026 Oseltamivir phos… 1 Mar 2026: 1 Apr 2026: 1

Source: NHSBSA Prescription Cost Analysis, to April 2026

Dolutegravir/Abacavir/Lamivudine versus Oseltamivir phosphate, April 2026
Measure Dolutegravir/Abacavir/Lamivudine Oseltamivir phosphate
Items, April 2026 1 336
Items, last 12 months 2 37,292
Net ingredient cost, April 2026 £798 £5,074

See the full profile for Dolutegravir/Abacavir/Lamivudine or Oseltamivir phosphate.